ArticleNeoplasia (New York, N.Y.)2010

Glutamate receptor GRIA3--target of CUX1 and mediator of tumor progression in pancreatic cancer.

Stefanie Ripka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.